分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

HERV2365 upregulates FGF1 expression by sponging miR-326 to promote the progression of intrahepatic cholangiocarcinoma

Yang Zhong, Xin Jiang, Fei Wang, Jianbin Xiao, Qiang Feng, Guixian Ye, Zefeng Gao, Jianmin Wang, Jingfeng Liu

Journal:iScience

IF:4.5

DOI:10.1016/j.isci.2026.115852

PMID:42164859

Published:2026-04-22

research field:肿瘤学分子生物学癌症研究非编码RNA肝脏病学

Abstract

Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with a dismal prognosis, underscoring the need to identify previously unrecognized molecular regulators involved in ICC progression. Although human endogenous retroviruses (HERVs) are aberrantly activated in multiple malignancies, their role in ICC remains poorly defined. Here, through integrative profiling of bulk and single-cell transcriptomes, we identified HERV2365 as a key upregulated oncogenic factor, which was enriched in ICC malignant cells and associated with poor prognosis. Functional assays demonstrated that HERV2365 enhanced ICC proliferation and tumorigenesis both in vitro and in vivo . Mechanistically, HERV2365 sponged miR-326, thereby derepressing fibroblast growth factor 1 (FGF1) and promoting tumor growth. Collectively, our findings identified HERV2365 as an unfavorable prognostic marker by promoting ICC progression through regulating the miR-326/FGF1 axis. Hepatology; Molecular biology; Cancer

本文使用的Yeasen产品

购物车
客服
转染试用